UiPath Inc. (PATH) PT Lowered to $18 at BofA Securities
Get Alerts PATH Hot Sheet
Price: $15.88 +0.63%
Rating Summary:
8 Buy, 18 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 12 | New: 20
Rating Summary:
8 Buy, 18 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 12 | New: 20
Join SI Premium – FREE
BofA Securities analyst Brad Sills lowered the price target on UiPath Inc. (NYSE: PATH) to $18.00 (from $20.00) while maintaining a Buy rating.
You May Also Be Interested In
- Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
- HCA Healthcare Inc (HCA) PT Lowered to $425 at JPMorgan
- Edgewise Therapeutics (EWTX) PT Raised to $60 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share